Author

Narjous CHAWKI

ANTI-USTEKINUMAB ANTIBODIES USING A DRUG TOLERANT ASSAY IS THE ONLY PREDICTIVE FACTOR OF CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENT UNDER USTEKINUMAB
ANTI-USTEKINUMAB ANTIBODIES USING A DRUG TOLERANT ASSAY IS THE ONLY PREDICTIVE FACTOR OF CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENT UNDER USTEKINUMAB

Narjous CHAWKI  et al.

Item 1 - 1 / 1
1